A Simple, Easy & Attractive Buy:

Simply sign up for the FREE Cabot Wealth Advisory and we'll immediately give you this latest research report ... absolutely FREE:

My Favorite ETF for 2012

With all the volatility individual stocks have seen lately, you may be looking for an alternative investment. We suggest exchange-traded funds (ETFs), which are investment funds that are traded on stock exchanges. ETFs hold assets like stocks, commodities or bonds, making them less risky than most individual stocks. This report contains our favorite ETF for 2012. It's an ETF that has shown to be a steady performer in the past six months, while the stock market has produced not much more than extreme volatility.

The Cabot Wealth Advisory e-letter delivers independent, no-nonsense investment advice, focusing on growth stocks, emerging markets stocks, value stocks and more. You'll learn about hot new stocks and the market timing systems you need to profit from them. We work hard to help you make money! Get it today.

Report image

Enter Email Address:

We Value Your Privacy

Not interested or already a Cabot Wealth Advisory reader?
Click here to never see this message again.

Walgreen, Omnicare Swap Home Services Operations

by on September 07, 2010
Walgreen (WAG) announced that its sales rose 2.1% in August, and disclosed that it will exchange most of its long-term-care pharmacy business for substantially all of Omnicare’s (OCR) home-infusion operations, the Wall Street Journal reported.
 
The swap comes as Walgreen, the nation’s largest drug store chain, determined that it couldn’t be a leader in the field of distributing medicine to senior living and hospice facilities without significant additional investment, reported the Journal.
 
Walgreen continues to expand. The company increased the number of its retail drug stores by 566 since a year ago, including the acquisition of 258 Duane Reade stores in April. This week, Walgreen agreed to buy the assets of 18 pharmacies from Graymark Healthcare, according to the Journal.
 
Meanwhile, Omnicare has sought to build its drug-distribution business and shed ancillary operations, amid sharply lower second-quarter earnings results and management changes including the retirement of its CEO in August the Journal reported.

Walgreen and Omnicare are Cabot Benjamin Graham Value Letter stocks.

 

Our Free Newsletter

Cabot Wealth Advisory delivers independent, no-nonsense investment advice on how to build long-lasting wealth. Learn about new hot stocks & the market timing indicators to profit from them. Simply enter your email address below - Start today!

We Value Your Privacy